Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 985 | 1004 | 1073 | 666 | 795 | 1026 |
Fund Return | -1.46% | 0.42% | 7.32% | -12.65% | -4.49% | 0.26% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Funds Global Emerging Markets Equia | 369.78M | 5.86 | -6.46 | 3.47 | ||
HGlobal EM Equity Class IC | 369.78M | 5.47 | -7.32 | 2.60 | ||
HGlobal EM Equity Class S1D | 369.78M | 5.56 | -7.12 | 2.82 | ||
HSBC Glbl EM Eq Class PD AUD | 369.78M | 5.31 | -7.64 | 2.25 | ||
HSBC Glbl EM Eq Class PC AUD | 369.78M | 5.32 | -7.65 | 2.25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BlackRock World Healthscience A2 | 76.51M | -2.52 | 9.61 | - | ||
CapGroup NewPerspectiveLux Cadh AUD | 18.82B | 1.23 | 3.73 | - | ||
Investec Global Franchise A Inc2 | 8.41B | 1.14 | 3.36 | - | ||
AB FCP I AmerGrwth Pf AD AUD H Inc | 7.71B | 3.69 | 6.61 | - | ||
BlackRockGlblEnhancedEqYld A8 AUD H | 297.04M | 2.97 | 4.14 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Reliance Industries | INE002A01018 | 7.72 | 2,939.90 | +2.68% | |
Tencent Holdings | KYG875721634 | 6.23 | 374.80 | -1.78% | |
PETROBRAS PN | BRPETRACNPR6 | 5.38 | 38.38 | +0.47% | |
ITAUUNIBANCOPN EB N1 | BRITUBACNPR1 | 5.09 | 31.90 | +1.27% | |
Alibaba | KYG017191142 | 4.76 | 77.10 | 0.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review